On March 12, 2024, analyst Bruno Amorim from Goldman Sachs reiterated a Buy rating on Petrobras Brasileiro (NYSE:PBR) while adjusting...

Goldman Sachs analyst Adam Samuelson continues to recommend selling Cal-Maine Foods (NASDAQ: CALM) and has increased the price target to...

On March 12, 2024, analyst Emily Bodnar from HC Wainwright & Co. reaffirmed NovoCure (NASDAQ: NVCR) with a Neutral rating...

On March 12, 2024, PAR Technology (NYSE: PAR) received a significant upgrade from analyst Ishfaque Faruk at Sidoti & Co....

Analyst David Westenberg from Piper Sandler has once again voiced his opinion on Elanco Animal Health, giving it a Neutral...

Dear Steve, I wanted to express my gratitude for sharing your postage policy with us. Having clear guidelines in place...

Dan Ives of Wedbush is buzzing with excitement and positivity about the AI revolution, especially following Oracle's recent fiscal third-quarter...

Financial experts have been closely examining Marathon Oil (NYSE: MRO) and their findings have ranged from optimistic to pessimistic. Over...

Analysts have had mixed feelings about Camden Property Trust (NYSE:CPT) in the last quarter, with opinions ranging from bullish to...

Wells Fargo analyst Roger Read is bullish on Marathon Oil (NYSE:MRO), maintaining an Overweight rating and increasing the price target...